AACR Annual Meeting 2018: A Round-up of Practice-changing Lung Cancer Immunotherapy Clinical Trials
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...
Tag: Clinical trials
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...
Patient enrollment in clinical trials has long been on the minds of oncologists and researchers. In 1990, fewer than...
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...
On March 23, the U.S. Food and Drug Administration announced the first-ever approval of a treatment for patients with...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
SABCS is a comprehensive scientific meeting that provides the latest information on prevention, diagnosis, and treatment of breast cancer...
Clinical trials are an essential part of cancer research. They ensure that scientific discoveries are translated into advances in...
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our...
Data presented at the AACR Annual Meeting 2016, on April 19, showed that a microdevice about the size of...
Immunotherapy was one of the hottest topics at last year’s AACR Annual Meeting, and this year the trend is...